Zu "288383-20-0" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Cediranib
Artikelnummer: Cay11495-5
Receptors for VEGF have central roles in vasculogenesis and angiogenesis and thus serve as targets for cancer therapy. Cediranib is a potent inhibitor of VEGF receptor tyrosine kinases, including VEGFR1, 2, and 3 (IC50s = 5, 1, and 3 nM, respectively). It also potently inhibits a variety of other receptor and...
| Schlagworte: | AZD 2171, ZD 2171, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-quinazoline |
| Anwendung: | VEGFR1/2/3 inhibitor |
| CAS | 288383-20-0 |
| MW: | 450.5 D |
ab 119,00 €
Cediranib
Artikelnummer: LKT-C1613.100
Cediranib is a potent antitumor and antiangiogenic compound. It inhibits vascular endotheial growth factor(VEGF) receptor tyrosine kinases.
| Schlagworte: | AZD2171 |
| Anwendung: | VEGF receptor tyrosine kinase inhibitor |
| CAS | 288383-20-0 |
| MW: | 450,51 D |
ab 193,00 €
Cediranib, Free Base (AZD2171, NSC-732208, Recentin, CAS...
Artikelnummer: LC-C-4300_100mg
Soluble in DMSO
| Schlagworte: | AZD 2171, Recentin(TM), ZD 2171, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-quinazoline |
| Anwendung: | VEGFR1/2/3 inhibitor |
| CAS | 288383-20-0 |
| MW: | 450,51 D |
ab 109,00 €
